Terence Friedlander, MD, University of California, San Francisco, remarks on the exciting bladder cancer data discussed during the Uromigos Live & Unplugged 2023 event.
He also provides his take on CheckMate 901 and the enfortumab vedotin/pembrolizumab combination.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.